672 related articles for article (PubMed ID: 19707253)
1. The benefits and risks of testosterone replacement therapy: a review.
Bassil N; Alkaade S; Morley JE
Ther Clin Risk Manag; 2009 Jun; 5(3):427-48. PubMed ID: 19707253
[TBL] [Abstract][Full Text] [Related]
2. Late-life onset hypogonadism: a review.
Bassil N; Morley JE
Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
[TBL] [Abstract][Full Text] [Related]
3. Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men.
Borst SE; Yarrow JF
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1035-42. PubMed ID: 25898953
[TBL] [Abstract][Full Text] [Related]
4. EMAS position statement: Testosterone replacement therapy in older men.
Kanakis GA; Pofi R; Goulis DG; Isidori AM; Armeni E; Erel CT; Fistonić I; Hillard T; Hirschberg AL; Meczekalski B; Mendoza N; Mueck AO; Simoncini T; Stute P; van Dijken D; Rees M; Lambrinoudaki I
Maturitas; 2023 Dec; 178():107854. PubMed ID: 37845136
[TBL] [Abstract][Full Text] [Related]
5. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).
Rosen RC; Wu F; Behre HM; Porst H; Meuleman EJH; Maggi M; Romero-Otero J; Martinez-Salamanca JI; Jones TH; Debruyne FMJ; Kurth KH; Hackett GI; Quinton R; Stroberg P; Reisman Y; Pescatori ES; Morales A; Bassas L; Cruz N; Cunningham GR; Wheaton OA;
J Sex Med; 2017 Sep; 14(9):1104-1115. PubMed ID: 28781213
[TBL] [Abstract][Full Text] [Related]
6. Hypogonadism in the man with erectile dysfunction: what to look for and when to treat.
Lazarou S; Morgentaler A
Curr Urol Rep; 2005 Nov; 6(6):476-81. PubMed ID: 16238923
[TBL] [Abstract][Full Text] [Related]
7. Testosterone Therapy: What We Have Learned From Trials.
Corona G; Torres LO; Maggi M
J Sex Med; 2020 Mar; 17(3):447-460. PubMed ID: 31928918
[TBL] [Abstract][Full Text] [Related]
8. EMAS position statement: Testosterone replacement therapy in the aging male.
Dimopoulou C; Ceausu I; Depypere H; Lambrinoudaki I; Mueck A; Pérez-López FR; Rees M; van der Schouw YT; Senturk LM; Simonsini T; Stevenson JC; Stute P; Goulis DG
Maturitas; 2016 Feb; 84():94-9. PubMed ID: 26614257
[TBL] [Abstract][Full Text] [Related]
9. Testosterone supplementation therapy for older men: potential benefits and risks.
Gruenewald DA; Matsumoto AM
J Am Geriatr Soc; 2003 Jan; 51(1):101-15; discussion 115. PubMed ID: 12534854
[TBL] [Abstract][Full Text] [Related]
10. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism.
Pencina KM; Travison TG; Cunningham GR; Lincoff AM; Nissen SE; Khera M; Miller MG; Flevaris P; Li X; Wannemuehler K; Bhasin S
J Clin Endocrinol Metab; 2024 Jan; 109(2):569-580. PubMed ID: 37589949
[TBL] [Abstract][Full Text] [Related]
11. European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology.
Corona G; Goulis DG; Huhtaniemi I; Zitzmann M; Toppari J; Forti G; Vanderschueren D; Wu FC
Andrology; 2020 Sep; 8(5):970-987. PubMed ID: 32026626
[TBL] [Abstract][Full Text] [Related]
12. Testosterone Replacement Therapy and Mortality in Older Men.
Hackett GI
Drug Saf; 2016 Feb; 39(2):117-30. PubMed ID: 26482385
[TBL] [Abstract][Full Text] [Related]
13. Testosterone replacement therapy: clinical considerations.
Luther PM; Spillers NJ; Talbot NC; Sinnathamby ES; Ellison D; Kelkar RA; Ahmadzadeh S; Shekoohi S; Kaye AD
Expert Opin Pharmacother; 2024; 25(1):25-35. PubMed ID: 38229462
[TBL] [Abstract][Full Text] [Related]
14. An update on the role of testosterone replacement therapy in the management of hypogonadism.
Hackett G
Ther Adv Urol; 2016 Apr; 8(2):147-60. PubMed ID: 27034727
[TBL] [Abstract][Full Text] [Related]
15. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
Miner M; Canty DJ; Shabsigh R
Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
[TBL] [Abstract][Full Text] [Related]
16. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
Traish AM
Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
[TBL] [Abstract][Full Text] [Related]
17. Body composition changes with testosterone replacement therapy following spinal cord injury and aging: A mini review.
Nightingale TE; Moore P; Harman J; Khalil R; Gill RS; Castillo T; Adler RA; Gorgey AS
J Spinal Cord Med; 2018 Nov; 41(6):624-636. PubMed ID: 28770686
[TBL] [Abstract][Full Text] [Related]
18. Late-onset hypogonadism.
Bassil N
Med Clin North Am; 2011 May; 95(3):507-23, x. PubMed ID: 21549875
[TBL] [Abstract][Full Text] [Related]
19. Adverse effects of testosterone replacement therapy: an update on the evidence and controversy.
Grech A; Breck J; Heidelbaugh J
Ther Adv Drug Saf; 2014 Oct; 5(5):190-200. PubMed ID: 25360240
[TBL] [Abstract][Full Text] [Related]
20. Risks and benefits of late onset hypogonadism treatment: an expert opinion.
Corona G; Vignozzi L; Sforza A; Maggi M
World J Mens Health; 2013 Aug; 31(2):103-25. PubMed ID: 24044106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
